Shares of Canopy Growth Corp (TSE:WEED – Get Free Report) have been assigned an average rating of “Reduce” from the six ratings firms that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is C$6.45.
Several equities analysts have weighed in on WEED shares. Canaccord Genuity Group dropped their price objective on Canopy Growth from C$5.00 to C$3.50 and set a “sell” rating for the company in a report on Monday, August 12th. Alliance Global Partners lifted their price target on Canopy Growth from C$6.00 to C$11.00 in a research note on Tuesday, June 4th. CIBC lowered their price objective on Canopy Growth from C$4.50 to C$4.00 and set an “underperform” rating for the company in a research note on Friday, May 31st. Jefferies Financial Group lifted their target price on shares of Canopy Growth from C$4.90 to C$10.63 and gave the stock a “hold” rating in a research report on Tuesday, June 11th. Finally, ATB Capital set a C$10.00 price target on shares of Canopy Growth and gave the company a “sector perform” rating in a research report on Tuesday, June 18th.
View Our Latest Analysis on Canopy Growth
Canopy Growth Price Performance
Insider Transactions at Canopy Growth
In related news, Senior Officer Christelle Gedeon sold 16,788 shares of the business’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of C$8.35, for a total value of C$140,253.67. In other Canopy Growth news, Director David Eric Klein sold 40,135 shares of the firm’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of C$8.35, for a total value of C$335,303.84. Also, Senior Officer Christelle Gedeon sold 16,788 shares of the business’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of C$8.35, for a total transaction of C$140,253.67. Insiders own 0.27% of the company’s stock.
Canopy Growth Company Profile
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Read More
- Five stocks we like better than Canopy Growth
- How Investors Can Find the Best Cheap Dividend Stocks
- 3 Leveraged ETFs to Multiply Returns
- What is a Stock Market Index and How Do You Use Them?
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- How Can Investors Benefit From After-Hours Trading
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.